{"id":"https://openalex.org/W4253787696","doi":"https://doi.org/10.1201/9781420037494-40","title":"Risk-Adapted Intravenous Melphalan with Adjuvant Thalidomide and Dexamethasone for Newly Diagnosed Untreated Patients with Systemic AL Amyloidosis: Interim Report of a Phase II Trial","display_name":"Risk-Adapted Intravenous Melphalan with Adjuvant Thalidomide and Dexamethasone for Newly Diagnosed Untreated Patients with Systemic AL Amyloidosis: Interim Report of a Phase II Trial","alternate_titles":[],"publication_year":2004,"publication_date":"2004-11-29","ids":{"openalex":"https://openalex.org/W4253787696","doi":"https://doi.org/10.1201/9781420037494-40"},"language":"en","primary_location":{"id":"doi:10.1201/9781420037494-40","doi":"https://doi.org/10.1201/9781420037494-40","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781420037494-40","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["CRC Press","Taylor & Francis","Informa"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Amyloid and Amyloidosis","raw_type":"book-chapter"},"parent_works":[{"id":"https://openalex.org/W2480395719","display_name":"Amyloid and Amyloidosis","relationship":"volume"}],"lineage":["https://openalex.org/W4253787696","https://openalex.org/W2480395719"],"child_works_count":0,"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074859256","display_name":"R Comenzo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rl Comenzo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089437787","display_name":"P. Zhou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Zhou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011172699","display_name":"L. Reich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Reich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014998267","display_name":"S. Costello","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Costello","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012472032","display_name":"A. Quinn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Quinn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083479007","display_name":"Sophia Fircanis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Fircanis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002815412","display_name":"L. Drake","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Drake","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027573348","display_name":"C. Hedvat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Hedvat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071873190","display_name":"Julie Teruya\u2010Feldstein","orcid":"https://orcid.org/0000-0003-0033-445X","observed_orcids":["https://orcid.org/0000-0003-0033-445X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Teruya-Feldstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004781977","display_name":"Da Filippa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Da Filippa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"M. Fleisher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Fleisher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"112","last_page":"114"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11638","display_name":"Cardiac tumors and thrombi","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/systemic-amyloidosis","display_name":"systemic amyloidosis","score":0.8080000281333923},{"id":"https://openalex.org/keywords/al-amyloidosis","display_name":"AL amyloidosis","score":0.8040000200271606},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.984000027179718},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9869999885559082},{"id":"https://openalex.org/keywords/plasma-cell-dyscrasia","display_name":"plasma cell dyscrasia","score":0.8259999752044678},{"id":"https://openalex.org/keywords/hematological-response","display_name":"hematologic response","score":0.7260000109672546},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.6629999876022339},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.5019999742507935}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8321666121482849},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.818751335144043},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.7353677749633789},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.7128593921661377},{"id":"https://openalex.org/C2779551797","wikidata":"https://www.wikidata.org/wiki/Q4652470","display_name":"AL amyloidosis","level":4,"score":0.6191625595092773},{"id":"https://openalex.org/C2776957806","wikidata":"https://www.wikidata.org/wiki/Q4895105","display_name":"Interim","level":2,"score":0.5718343257904053},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.5003397464752197},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.444083034992218},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4367726445198059},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3478736877441406},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.30853521823883057},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.11387985944747925},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.09557822346687317},{"id":"https://openalex.org/C36394416","wikidata":"https://www.wikidata.org/wiki/Q949267","display_name":"Immunoglobulin light chain","level":3,"score":0.0},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1201/9781420037494-40","doi":"https://doi.org/10.1201/9781420037494-40","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781420037494-40","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["CRC Press","Taylor & Francis","Informa"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Amyloid and Amyloidosis","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W20936464"],"related_works":["https://openalex.org/W2147850209","https://openalex.org/W2584850079","https://openalex.org/W2502062119","https://openalex.org/W2530372290","https://openalex.org/W2056797282","https://openalex.org/W2588941643","https://openalex.org/W2039282816","https://openalex.org/W829707271","https://openalex.org/W2569525785","https://openalex.org/W2316385782"],"abstract_inverted_index":{"From":[0],"clinical":[1],"trials":[2],"employing":[3],"intravenous":[4],"(iv)":[5],"melphalan":[6],"and":[7,40,66,75,78,86],"mobilized":[8],"stem":[9],"cell":[10,47,55],"support":[11],"for":[12],"patients":[13,93],"with":[14,32,52,63,95,134],"systemic":[15],"Primary":[16,71],"amyloidosis":[17],"(AL)":[18],"one":[19],"should":[20],"learned":[21],"that":[22],"survival":[23],"depends":[24],"on":[25,34,41,125],"the":[26,35,42,45,101,113,122],"number":[27],"of":[28,37,44,92,103,115,127],"major":[29],"viscera":[30],"involved":[31],"amyloid,":[33],"degree":[36],"cardiac":[38],"involvement,":[39],"response":[43],"plasma":[46,54],"disease":[48,56],"to":[49,88,109],"melphalan.":[50],"Patients":[51],"persistent":[53],"at":[57],"3":[58],"months":[59],"receive":[60],"adjuvant":[61,82,116],"therapy":[62,83,117],"either":[64],"thalidomide":[65,135],"dexamethasone":[67,69],"or":[68],"alone.":[70],"endpoints":[72],"are":[73],"survival,":[74],"organ":[76],"system":[77],"hematologic":[79,98],"responses.":[80],"Furthermore,":[81],"is":[84,107,118,124],"feasible":[85],"appears":[87],"benefit":[89],"about":[90],"30%":[91],"(4/13)":[94],"improvement":[96],"in":[97,119,136],"response,":[99],"including":[100],"achievement":[102],"light":[104],"microscopy.":[105],"It":[106],"important":[108],"note":[110],"how":[111],"tailored":[112],"use":[114],"this":[120],"trial;":[121],"emphasis":[123],"tolerance":[126],"these":[128],"drugs,":[129],"a":[130],"problem":[131],"area":[132],"particularly":[133],"AL":[137],"patients.":[138]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4253787696","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-05-12T00:00:00"}
